Trial Profile
An Open-label, Randomized, Cross Over Single Oral Dose Study Comparing the Pharmacokinetics of Different Formulations of AZD9977 (Part A) and Influence of Food (Part B) in Healthy Male Subjects
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 29 Jan 2016
Price :
$35
*
At a glance
- Drugs Balcinrenone (Primary) ; Balcinrenone (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 08 Jan 2016 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by Clinicaltrials.gov record.
- 29 Sep 2015 New trial record